OTC · Drug Manufacturers - Specialty & Generic

Antisense Therapeutics Limited (ATHJF) Stock

$0.01 -76.00% OTC: ATHJF Healthcare

Antisense Therapeutics Limited (ATHJF) is an Australian biotechnology company dedicated to the research and development of innovative antisense pharmaceuticals. Its therapeutic pipeline includes two primary drug candidates.

Valuation

MetricValue
Price$0.01
Market Cap$19.64M
P/E Ratio-1.00
P/B Ratio2.18
P/S Ratio5.35
EPS (TTM)$-0.01
52-Week High$0.08
52-Week Low$0.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-133.33%
ROA-80.00%
ROCE-120.00%
Gross Margin97.91%
Operating Margin-398.65%
Net Margin-401.57%
Debt/Equity0.00
Current Ratio2.81

Annual Financials (USD)

Metric20202021202220232024
Revenue$1.0M$1.0M$2.0M$2.0M$3.0M
Operating Profit$-7.0M$-9.0M$-8.0M$-13.0M$-12.0M
Net Profit$-6.0M$-8.0M$-6.0M$-11.0M$-12.0M
EPS$-0.01$-0.01$-0.01$-0.02$-0.01
Op Margin-997.3%-1502.9%-428.1%-844.7%-398.6%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$5.0M$7.0M$22.0M$13.0M$15.0M
Total Liabilities$1.0M$1.0M$1.0M$3.0M$5.0M
Cash$4.0M$6.0M$19.0M$11.0M$12.0M
Borrowings$0$0$0$0$0

Latest News

Dow Jones Futures Fall, Netflix Dives, SpaceX Scrubs Launch After Latest AI Sell-Off Investor's Business Daily · Jul 17, 2026 Struggling Android phone maker prepares to pull out of US TheStreet · Jul 17, 2026 Uniper targets data centres in strategy shift, plans €5 billion in investment Reuters · Jul 17, 2026 Brookfield Wealth Solutions Wins Shareholder Approval for Brookfield Corp. Tie-Up MarketBeat · Jul 17, 2026 ManpowerGroup (MAN) Rockets to Fresh High on Better-Than-Expected Q2 Insider Monkey · Jul 17, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-4.0M$-6.0M$-8.0M$-8.0M$-10.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$-1.0M$-2.0M$0$0
Net Cash Flow$1.0M$2.0M$13.0M$-8.0M$1.0M
Free Cash Flow$-4.0M$-6.0M$-8.0M$-8.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-0.34
FCF Yield-50.93%
Quick Ratio2.81
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BFFTFBiofrontera AG $0.33 -95.24% -0.97 $19.35M 0.00%
GRAMFTPCO Holding Corp. $0.16 -15.36% -0.07 $20.12M 0.00%
KMSTFKadimastem Ltd $3.21 -3.02% -1.52 $9.50M 0.00%
NXTTFLifeist Wellness Inc. $0.04 -3.64% -1.27 $15.76M 0.00%
OCELOrganicell Regenerative Medicine, Inc. $2.74 -0.27% -4.73 $19.97M 0.00%

About Antisense Therapeutics Limited

Antisense Therapeutics Limited (ATHJF) is an Australian biotechnology company dedicated to the research and development of innovative antisense pharmaceuticals. Its therapeutic pipeline includes two primary drug candidates. ATL1102, an antisense inhibitor targeting CD49d, is currently in Phase II clinical trials for a variety of inflammatory conditions, such as multiple sclerosis, Duchenne Muscular Dystrophy, and asthma. The company's second candidate, ATL1103, is an advanced second-generation antisense medication. This drug works by blocking growth hormone receptor expression, which subsequently lowers levels of insulin-like growth factor-I (IGF-I) in the bloodstream, and has successfully completed Phase II clinical trials for diseases linked to excessive growth hormone activity. Antisense Therapeutics Limited was established in 2000 and operates from its base in Toorak, Australia.

Antisense Therapeutics Limited is headquartered in AU.

Antisense Therapeutics Limited (ATHJF) stock trades at $0.01 with a market capitalization of $19.64M. The stock is valued at a price-to-earnings (P/E) ratio of -1.00, price-to-book of 2.18, price-to-sales of 5.35. Over the past 52 weeks the stock has ranged between $0.01 and $0.08, and currently trades 87.5% below its 52-week high.

On profitability, Antisense Therapeutics Limited generates a return on equity (ROE) of -133.33%, return on capital employed of -120.00%, an operating margin of -398.65%, a net profit margin of -401.57%.

Official website: www.antisense.com.au

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides